Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Specific investigations: other studies

Currently viewing:

Administrative data

Endpoint:
endocrine system modulation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
single dose application, 48 h incubation of yeast cells
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
comparable to guideline study
Remarks:
comparable to OECD 455

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2016
Report date:
2016

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
other: OECD 455
Version / remarks:
the YES/YAS assay works with genetically modified yeast cells (human estrogen and androgen receptors hERa and hAR, reporter gene lac-Z for ß-galactosidase)
Deviations:
not applicable
Principles of method if other than guideline:
The YES/YAS assay uses genetically modified yeast cells, that can interact with the human estrogen and androgen receptors hERa and hAR. The reporter gene lac-Z, which encodes the enzyme ß-galactosidase is also integrated in the yeast cells.
If a test item interacts with the estrogen or androgen receptors, the reporter gene will be expressed and ß-galactosidase will be secreted into the medium. The medium contains an indicator (CPRG), which is converted by ß-galactosidase into a red product. This product can be measured photometrically.
The measured OD (at 570 nm) values correlate directly with the amount of produced ß-galactosidase, which is an indication of the test item's activity towards the hERa or hAR receptors.
GLP compliance:
yes (incl. QA statement)
Remarks:
certified by Landesamt für Umwelt, Wasserwirtschaft und Gewerbeaufsicht Rheinland-Pfalz, Kaiser-Friedrich-Str. 7, D-55116 Mainz, Germany
Type of method:
in vitro

Test material

Constituent 1
Chemical structure
Reference substance name:
9,9-Bis(methoxymethyl)-9H-fluorene
EC Number:
682-678-3
Cas Number:
182121-12-6
Molecular formula:
C17H18O2
IUPAC Name:
9,9-Bis(methoxymethyl)-9H-fluorene
Test material form:
solid: particulate/powder
Specific details on test material used for the study:
9,9-Bis(methoxymethyl)-9H-fluorenone, CAS No. 682-678-3, monoconstituent substance, homogeneous, solid, stable at room temperature
batch no. Mel-Sab-01, expiry date Dec. 2018, purity: >99%

Test animals

Species:
other: yeast (Saccharomyces cerevisiae), genetically modified
Strain:
other: yeast (Saccharomyces cerevisiae), genetically modified
Remarks:
hERa and hAR receptor, expression plasmid carrying the reporter gene lacZ
Sex:
not specified
Details on test animals or test system and environmental conditions:
The YES-YAS Assay Kit including Saccharomyces cerevisiae was obtained from Xenometrix AG, Gewerbestraße 25, CH-4123 Allschwil, Switzerland
batch No:: N05-12477
4 days before the start of the experiment, the yeast cultures were prepared in 2 different culture flasks (for YES and YAS assays respectively) and incubated at 32 +/- 1°C for 71h (YAS culture) or 95.5 h (YES culture) until the cultures were clearly turbid. Then the optical density at 690 nm for the growth of the yeast cells was measured with a microplate reader. The cultures were diluted appropriately and used for the experiment.

Administration / exposure

Route of administration:
other: dropped into culture cultureflasks
Vehicle:
DMSO
Details on exposure:
After checking the yeast cultures for growth with a microplate reader by measuring the optical density, 7 dilutions of positive controls and 8 dilutions of test item were pipetted into a 96-well dilution plate.
Next, 4 assay plates were labelled (YES Agonist/ YAS Agonist/ YES Antagonist/ YAS Antagonist) and filled with the corresponding assay medium. Then each positive control dilution and test item dilution was pipetted from the dilution plate to an assay plate in duplicate. After addition of the yeast cells the plates were incubated at 32 +/- 1°C in a humidity container with agitation. Colour change of the medium in the positive control wells indicated growth after 46 h.
Then, the well plates were measured with a microplate reader at 690 nm for cell growth and at 570 nm for colour development.
Evaluation was done with Microsoft Excel.

Analytical verification of doses or concentrations:
yes
Details on analytical verification of doses or concentrations:
microplate reader at 690 nm for cell growth and at 570 nm for colour development of positive controls and test item.
Duration of treatment / exposure:
46 h (indication by colour change of the positive controls)
Frequency of treatment:
single dose application
Doses / concentrationsopen allclose all
Dose / conc.:
0 other: mol/L
Remarks:
8 concentrations with half-log concentrations, up to 0.0001 mol/L
Dose / conc.:
0 other: mol/L
Dose / conc.:
0 other: mol/L
Dose / conc.:
0 other: mol/L
Dose / conc.:
0 other: mol/L
Dose / conc.:
0 other: mol/L
Dose / conc.:
0 other: mol/L
Dose / conc.:
0 other: mol/L
Details on study design:
8 dilutions of positive controls or test item were examined in duplicate.
YES or YAS agonistic activity was detected directly by ß-galctosidase activity. Antagonistic activities were detected by inhibition of ß-galactosidase activities in the presence of estrogenic or androgenic substances.
The solvent DMSO served as negative control. Cytotoxicity was checked by measurement of the cell density.

Examinations

Examinations:
Colour change by ß-galactosidasse activity
The ß-galactosidase activity correlates directly with the activating (agonist) or inhibiting (antagonist) activity of the test item.
Positive control:
YES Agonist assay: 17ß-estradiol (E2)
YES Antagonist assay: 4-hydroxytamoxifen (HT)
YAS Agonist assay: 5a-dihyrotestosterone (DHT)
YAS Antagonist assay: Flutamide (FL)

Results and discussion

Details on results:
The experiment was valid. 8 dilutions of the test item in DMSO and controls (solvent control and positive controls) were exposed to the modified yeast cells in duplicate. After incubation positive and solvent (negative) controls showed the expected results. No cytotoxicity was observed (controlled by measurement of the cell density). The test item showed no positive result in any assay. The values of ß-galactosidase activity and induction ratio of all test item dilutions lay in the same range as the values of the respective controls. No dose-response correlation was visible.
Therefore the test item is considered to have no estrogenic and androgenic agonistic and antagonistic activity under the conditions of this experiment.

Applicant's summary and conclusion

Conclusions:
The test item is considered to show no estrogenic or androgenic agonistic or antagonistic activities in the YES/YAS assay.